X

Aarti Drugs Ltd Q2FY24; 5% fall in Profits

Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API’s), Pharma Intermediates, Specialty Chemicals as well as Formulations.

Financial Results:

Aarti Drugs Ltd reported Revenues for Q2FY24 of ₹578.00 Crores down from ₹625.00 Crore year on year, a fall of 7.52%.

Total Expenses for Q2FY24 of ₹532.00 Crores down from ₹575.00 Crores year on year, a fall of 7.48%.

Consolidated Net Profit of ₹35.00 Crores down 5.41% from ₹37.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹3.73, down 5.57% from ₹3.95 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post